Latest news

ClinicalAugust 28, 2026

Despite a mid-stage failure, Bausch + Lomb moves a medication for dry eye condition to Phase 3

Bausch + Lomb had an investigational eye drop that failed to reach its primary efficacy endpoint in a mid-stage...

InsightsAugust 28, 2026

Top 10 Digital Risks Facing Biotech Companies

Executive Summary Biotechnology companies are becoming increasingly dependent on digital technologies to accelerate research, manage complex datasets, collaborate across global...

InsightsAugust 28, 2026

AI in GMP Compliance

Executive Summary Good Manufacturing Practice (GMP) compliance is becoming increasingly complex as pharmaceutical companies manage larger datasets, more sophisticated manufacturing...

InsightsAugust 24, 2026

The Future of Global Drug Regulation

Executive Summary Drug regulation is entering a period of significant transformation. For decades, pharmaceutical regulation has relied on established scientific standards,...

RegulatoryAugust 21, 2026

Phase 3 of Merck and Moderna’s customized cancer vaccine lowers recurrence, paving the way for approval

Key Trial Breakthrough in Skin Cancer The personalized mRNA cancer...

RegulatoryAugust 21, 2026

FDA Issues Warning Letters to Aurobindo’s Eugia Unit and Tianjin Kilo Pharmaceutical

The U.S. Food and Drug Administration (FDA) has issued...

Research & DevelopmentAugust 21, 2026

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Novo Nordisk has started a new late-stage clinical study to evaluate lower maintenance doses of its oral obesity treatment...

InsightsAugust 20, 2026

Quantum Computing and Drug Discovery

Executive Summary Pharmaceutical drug discovery is fundamentally a problem of understanding molecules. Researchers need to determine how compounds interact with biological...

RegulatoryAugust 20, 2026

After a GLP-1 inhibitor lowers blood sugar crashes in a Ph. 3 victory, Amylyx prepares to push for approval

A $35 Million GLP-1 Bet Pays Off It looks like Amylyx Pharmaceuticals' $35 million gamble on the GLP-1 receptor agonist...

ClinicalAugust 20, 2026

Biokin’s Iza-Bren Meets Primary Endpoint in Phase 3 Panku-Lung01 Lung Cancer Trial

Biokin Pharma reported positive results from the phase 3...

CommercialAugust 20, 2026

Leo Pharma Pens Mega Deal to Buy Tanabe’s Skin Disease Drug

Leo Pharma is continuing its push to expand its...

ClinicalAugust 18, 2026

Definium Bags Major Phase 3 Victory With LSD Formula

Definium Therapeutics has scored another phase 3 success with its LSD-based therapy, this time demonstrating positive results in generalized...

Research & DevelopmentAugust 18, 2026

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

New research involving infant macaques has produced findings that may support further investigation of CytoDyn’s CCR5-targeting antibody leronlimab in...

InsightsAugust 17, 2026

Why Data Is Becoming Pharma’s Most Valuable Asset

Pharma's:Executive Summary For decades, pharmaceutical companies have built competitive advantage around scientific expertise, intellectual property, manufacturing capabilities, commercial reach, and...